AbSci
  • Our Technology
  • Partnerships
  • About Us
  • Careers
  • News / Updates
  • Contact
  • Facebook
  • Twitter
  • Linkedin
Select Page
AbSci Establishes New Collaboration with Sanofi  

AbSci Establishes New Collaboration with Sanofi  

Jan 9, 2019 | Announcement, News, Press

“This collaboration illustrates the need for new expression technologies that are capable of producing these next-generation antibody and protein scaffolds. We’ve shown SoluProTM can uniquely deliver on this industry need.”

AbSci Appoints Andrew J.S. Jones, D. Phil to Scientific Advisory Board

AbSci Appoints Andrew J.S. Jones, D. Phil to Scientific Advisory Board

Oct 2, 2018 | Announcement

“It is rejuvenating to be working with a young and energetic company like AbSci. Their exciting technology not only has dramatic development, yield and production speed advantages for manufacture of complex biopharmaceuticals,” – Andrew J.S. Jones, D. Phil

AbSci to attend BIO-Europe 2018, 5th – 7th November 2018, in Copenhagen, Denmark

Sep 14, 2018 | Announcement

  AbSci to attend the Bio-Europe 2018 conference in Copenhagen, Denmark from 5th – 7th November 2018   If you would like to meet with an AbSci Business Development professional, please email us at partnering at...
AbSci Raises Oversubscribed $12M Series C to Fuel Commercialization of Its Groundbreaking Protein Expression Platform

AbSci Raises Oversubscribed $12M Series C to Fuel Commercialization of Its Groundbreaking Protein Expression Platform

May 29, 2018 | Announcement, Fundraising

The Series C Round led by Asahi Glass Co., Ltd. “AGC” includes participation from all prior investors (Phoenix Venture Partners, Oregon Venture Fund, WRF Capital, and Souther Co.) and new investors Columbia Ventures Corporation and GreenBridge.

Sean McClain of AbSci Entrepreneur Of The Year® 2018 Award Finalist in the Pacific Northwest

May 9, 2018 | Announcement, News, Press

EY Announces Sean McClain of AbSci Entrepreneur Of The Year® 2018 Award Finalist in the Pacific Northwest region Vancouver, Washington May 7th, 2018 – EY announced that Founder and CEO Sean McClain of AbSci is a finalist for the Entrepreneur Of The Year® 2018 Award in...
AbSci Adds Protein Characterization Expert, Alan Herman, PhD to Scientific Advisory Board

AbSci Adds Protein Characterization Expert, Alan Herman, PhD to Scientific Advisory Board

Feb 5, 2018 | Announcement, Press

“There’s an electricity of discovery here like Genentech and Amgen,” said Dr. Herman. “AbSci’s ability to fold proteins is an innovative art form. This technology enables more efficient manufacturing, which will bring down the price of drugs.”

« Older Entries

Recent Posts

  • Sanofi turns to high titer E. Coli platform in AbSci deal
  • AbSci Establishes New Collaboration with Sanofi  
  • SoluPro™ featured in Science Magazine
  • AbSci’s Founder and CEO, Sean McClain, named to Forbes 30 Under 30 list in Science 2019
  • AbSci Appoints Andrew J.S. Jones, D. Phil to Scientific Advisory Board

Archives

  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • July 2018
  • May 2018
  • February 2018
  • January 2018
  • December 2017
  • October 2017
  • August 2017
  • April 2017
  • January 2017
  • October 2016
  • August 2016
  • May 2016
  • April 2016
  • October 2015
SEE ARCHIVE

Categories

  • Announcement
  • Article
  • Award
  • Fundraising
  • News
  • Press

    Designed by Elegant Themes | Powered by WordPress